Warning Cognizant Technology Solutions (CTSH) optimists! John Fox just Unloaded 6,000 shares.; Iguana Healthcare Management Has Trimmed Dermira (DERM) Position

February 17, 2018 - By Michael Collier

The director of Cognizant Technology Solutions Corp, John Fox has made a surprising deal in the ‘s company that is with a total value of $478,981 U.S Dollars. As exposed in the D.C. based-SEC form filed on 16-02-2018, John sold 6,000 shares which is based on a market stock price per share of $79.8. At the moment, John Fox owns 35,590 shares which are equivalent to roughly 0.01% of the company’s market capitalization.

Iguana Healthcare Management Llc decreased Dermira Inc (DERM) stake by 10.71% reported in 2017Q3 SEC filing. Iguana Healthcare Management Llc sold 15,000 shares as Dermira Inc (DERM)’s stock declined 17.23%. The Iguana Healthcare Management Llc holds 125,000 shares with $3.38 million value, down from 140,000 last quarter. Dermira Inc now has $1.15 billion valuation. The stock decreased 2.69% or $0.76 during the last trading session, reaching $27.49. About 747,017 shares traded or 19.76% up from the average. Dermira, Inc. (NASDAQ:DERM) has declined 7.44% since February 17, 2017 and is downtrending. It has underperformed by 24.14% the S&P500.

The stock decreased 0.52% or $0.42 during the last trading session, reaching $80.95. About 4.78M shares traded or 20.58% up from the average. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has risen 5.50% since February 17, 2017 and is uptrending. It has underperformed by 11.20% the S&P500.

Cognizant Technology Solutions Corporation provides information technology , activities and technology consulting, infrastructure, and business process services worldwide. The company has market cap of $47.73 billion. The firm operates through four divisions: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. It has a 32 P/E ratio. The Company’s consulting and technology services include strategy consulting, business and activities consulting, technology strategy and change management, and program management consulting services; application design and development; systems integration; and application testing, consulting, and engineering services, as well as enterprise information management services.

Among 33 analysts covering Cognizant Technology Solutions Corp. (NASDAQ:CTSH), 25 have Buy rating, 1 Sell and 7 Hold. Therefore 76% are positive. Cognizant Technology Solutions Corp. has $100.0 highest and $48 lowest target. $83.73’s average target is 3.43% above currents $80.95 stock price. Cognizant Technology Solutions Corp. had 89 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has “Buy” rating given on Tuesday, February 9 by Needham. As per Friday, February 19, the company rating was initiated by Cowen & Co. The rating was maintained by Citigroup with “Neutral” on Tuesday, October 31. The firm has “Buy” rating by BMO Capital Markets given on Thursday, August 3. The rating was maintained by Cowen & Co on Wednesday, November 1 with “Buy”. The stock has “Buy” rating by SunTrust on Thursday, September 10. The firm earned “Sell” rating on Monday, August 10 by Zacks. The rating was upgraded by Needham on Wednesday, November 1 to “Strong Buy”. As per Monday, October 3, the company rating was maintained by Citigroup. The rating was maintained by BMO Capital Markets with “Outperform” on Thursday, February 8.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.27, from 0.76 in 2017Q2. It improved, as 37 investors sold Cognizant Technology Solutions Corporation shares while 296 reduced holdings. 99 funds opened positions while 244 raised stakes. 487.81 million shares or 3.03% less from 503.05 million shares in 2017Q2 were reported. Pine River Capital Mgmt Limited Partnership accumulated 0.1% or 9,130 shares. Wealthtrust holds 0.01% or 256 shares. Hirtle Callaghan & Ltd stated it has 368 shares. Eulav Asset Mngmt owns 37,000 shares for 0.13% of their portfolio. Bluecrest Capital Mngmt holds 0.01% or 3,347 shares in its portfolio. Lucus Advisors Lc invested in 0.77% or 7,510 shares. Credit Suisse Ag reported 1.11M shares or 0.08% of all its holdings. 611,250 were reported by Schwartz Inv Counsel. Liberty Management has 34,588 shares. Greenleaf holds 0.16% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 102,868 shares. Comerica Securities reported 0.08% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). 15,865 are owned by Boltwood Capital Mngmt. San Francisco Sentry Invest Group (Ca), California-based fund reported 584 shares. Canada Pension Plan Board owns 0.11% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 761,326 shares. Retirement Of Alabama accumulated 0.11% or 286,543 shares.

Since August 15, 2017, it had 0 buys, and 37 insider sales for $59.40 million activity. The insider Veeraraghavachary Srinivasan sold $182,500. Shares for $216,543 were sold by Kandiah Gajakarnan Vibushanan. Shares for $576,012 were sold by GOMATAM SUMITHRA. $830,705 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) shares were sold by KLEIN JOHN E. Mehta Rajeev had sold 42,563 shares worth $3.30M. Shares for $123,456 were sold by Lennox James Patrick on Thursday, September 7. CHATTERJEE DEBASHIS had sold 1,726 shares worth $125,998 on Tuesday, September 12.

Iguana Healthcare Management Llc increased Ignyta Inc (NASDAQ:RXDX) stake by 75,000 shares to 125,000 valued at $1.54 million in 2017Q3. It also upped Abbvie Inc (NYSE:ABBV) stake by 25,000 shares and now owns 65,000 shares. Tesaro Inc (NASDAQ:TSRO) was raised too.

Investors sentiment increased to 2.03 in Q3 2017. Its up 0.64, from 1.39 in 2017Q2. It improved, as 15 investors sold DERM shares while 21 reduced holdings. 22 funds opened positions while 51 raised stakes. 41.09 million shares or 3.89% more from 39.55 million shares in 2017Q2 were reported. Moreover, Teachers Retirement Sys Of The State Of Kentucky has 0.01% invested in Dermira, Inc. (NASDAQ:DERM) for 32,910 shares. Ardsley Advisory Ptnrs holds 10,000 shares or 0.04% of its portfolio. Nationwide Fund Advisors stated it has 48,868 shares or 0.01% of all its holdings. Susquehanna Gp Llp holds 0% of its portfolio in Dermira, Inc. (NASDAQ:DERM) for 48,511 shares. Voya Management accumulated 1.47M shares. Barclays Public Ltd Liability Company invested in 1,241 shares or 0% of the stock. Timessquare Mgmt Lc has invested 0.41% of its portfolio in Dermira, Inc. (NASDAQ:DERM). Rhumbline Advisers stated it has 44,381 shares or 0% of all its holdings. Sei Invests Commerce invested in 155,300 shares. State Street Corp accumulated 864,355 shares or 0% of the stock. Price T Rowe Associate Md reported 2.41M shares. Renaissance Tech Ltd accumulated 0% or 96,900 shares. Numeric Limited Liability Com owns 0.01% invested in Dermira, Inc. (NASDAQ:DERM) for 42,543 shares. Cubist Systematic Strategies Ltd Liability Com accumulated 55 shares. 3,885 are held by Bnp Paribas Arbitrage Sa.

Since August 28, 2017, it had 0 insider purchases, and 13 sales for $1.59 million activity. 3,000 shares valued at $85,642 were sold by BAUER EUGENE A on Thursday, February 1. Another trade for 600 shares valued at $14,286 was sold by Cohen David E. The insider WIGGANS THOMAS G sold $137,566. 18,458 shares were sold by Griffith Christopher M., worth $499,354.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: